Amedisys Having ‘Significant Conversations’ with Prospective Palliative Care Partners
Hospice News
DECEMBER 6, 2022
As Amedisys Inc. (Nasdaq: AMED) Chairman Paul Kusserow rejoins the C-suite as CEO, his list of priorities includes increasing clinician retention rates, leveraging innovation arm Contessa and returning to some degree of earnings predictability. Kusserow – who holds a reputation as a successful turnaround executive – held the Amedisys CEO role from 2014 until early 2022.
Let's personalize your content